Skip to main content
TipRanks
Go Ultimate75% OFF

BioStem Technologies (BSEM) Stock Statistics & Valuation Metrics

315 Followers

Total Valuation

BioStem Technologies has a market cap or net worth of $20.14M. The enterprise value is $55.39M.

Market Cap
$20.14M
Enterprise Value
$55.39M

Share Statistics

BioStem Technologies has 19,178,630 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
19,178,630
Owned by Insiders
1.05%
Owned by Institutions
4.52%

Financial Efficiency

BioStem Technologies’s return on equity (ROE) is -0.17 and return on invested capital (ROIC) is -1.62%.

Return on Equity (ROE)
-0.17
Return on Assets (ROA)
-0.13
Return on Invested Capital (ROIC)
-1.62%
Return on Capital Employed (ROCE)
-0.02
Revenue Per Employee
650.44K
Profits Per Employee
-90.15K
Employee Count
73
Asset Turnover
0.95
Inventory Turnover
1.13

Valuation Ratios

The current PE Ratio of BioStem Technologies is -0.45. BioStem Technologies’s PEG ratio is 0.01.

PE Ratio
-0.45
PS Ratio
-0.32
PB Ratio
1.02
Price to FCF
-1.57
Price to Operating Cash Flow
-1.52
PEG Ratio
0.01

Income Statement

In the last 12 months, BioStem Technologies had revenue of 47.48M and earned -6.58M in profits. Earnings per share was -0.39.

Revenue
47.48M
Gross Profit
44.22M
Operating Income
-689.15K
Pretax Income
-389.65K
Net Income
-6.58M
EBITDA
-308.13K
Earnings Per Share (EPS)
-0.39

Cash Flow

In the last 12 months, operating cash flow was -12.36M and capital expenditures -494,769, giving a free cash flow of -12.85M billion.

Operating Cash Flow
-12.36M
Free Cash Flow
-12.85M
Free Cash Flow per Share
-0.72

Dividends & Yields

BioStem Technologies pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-63.83%
Earnings Yield
-215.53%

Stock Price Statistics

Beta
1.88
52-Week Price Change
-74.64%
50-Day Moving Average
2.58
200-Day Moving Average
3.92
Relative Strength Index (RSI)
33.55
Average Volume (3m)
182.78K

Important Dates

BioStem Technologies upcoming earnings date is Apr 05, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 12, 2026
Next Earnings Date
Apr 05, 2027
Ex-Dividend Date
―

Financial Position

BioStem Technologies as a current ratio of 4.12, with Debt / Equity ratio of 8.51%

Current Ratio
4.12
Quick Ratio
3.85
Debt to Market Cap
0.05
Net Debt to EBITDA
85.09
Interest Coverage Ratio
0.00

Taxes

In the past 12 months, BioStem Technologies has paid 6.19M in taxes.

Income Tax
6.19M
Effective Tax Rate
-15.89

Enterprise Valuation

BioStem Technologies EV to EBITDA ratio is -0.60, with an EV/FCF ratio of -1.58.

EV to Sales
-0.32
EV to EBITDA
-0.60
EV to Free Cash Flow
-1.58
EV to Operating Cash Flow
-1.65

Balance Sheet

BioStem Technologies has $971.14K in cash and marketable securities with $1.17M in debt, giving a net cash position of -$194.68K billion.

Cash & Marketable Securities
$971.14K
Total Debt
$1.17M
Net Cash
-$194.68K
Net Cash Per Share
-$0.01
Tangible Book Value Per Share
-$0.23

Margins

Gross margin is 116.59%, with operating margin of 54.74%, and net profit margin of 64.03%.

Gross Margin
116.59%
Operating Margin
54.74%
Pretax Margin
57.78%
Net Profit Margin
64.03%
EBITDA Margin
53.91%
EBIT Margin
57.30%

Analyst Forecast

The average price target for BioStem Technologies is $7.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target
$7.00
Price Target Upside
566.67% Upside
Analyst Consensus
Moderate Buy
Analyst Count
1
Revenue Growth Forecast
-86.50%
EPS Growth Forecast
-291.62%

Scores

Smart Score
―
AI Score
44